Home › Companies › OVID THERAPEUTICS INC. › 2023-2024
At OVID THERAPEUTICS INC.'s shareholder meeting held June 6, 2024, in the 2023-2024 proxy season, 96 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 520 separate fund positions. On the most widely held item on that ballot — ADVISORY APPROVAL OF THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS. — OVID THERAPEUTICS INC.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: OVID THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 7, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and OVID THERAPEUTICS INC.’s Form 8-K, filed June 7, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 6, 2024: 4 items on OVID THERAPEUTICS INC.’s Form 8-K, filed June 7, 2024: 2 elected · 2 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2025-2026
Explore OVID THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are OVID THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 7, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Barbara Duncan | 36,686,822 | -- | -- | 5,581,389 | 16,235,602 | 87% | Elected | — |
| Elect Director: Robert Michael Poole | 40,158,684 | -- | -- | 2,109,527 | 16,235,602 | 95% | Elected | — |
| 2. The compensation paid to the Company's named executive officers, as disclosed in the Proxy Statement | 40,499,565 | 1,760,461 | 8,185 | -- | 16,235,602 | 96% | Approved | — |
| 3. The selection of KPMG LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024 | 57,201,432 | 1,293,006 | 9,375 | -- | -- | 98% | Approved | — |
Source: OVID THERAPEUTICS INC., Form 8-K, filed with the SEC on June 7, 2024 — read the filing on EDGAR.
Each item below shows how the 96 asset managers that disclosed a OVID THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: Election of Class I directors: Barbara Duncan
OVID THERAPEUTICS INC.’s own tally for this item (“Elect Director: Barbara Duncan”): 36,686,822 for, 5,581,389 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 : The Company's stockholders elected all of the nominees for director to serve a three-year term until the Company's 2027 annual meeting of stockholders, or until their respective successors are duly elected and qualified, by the votes set forth in the table below:”
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 7,897,046 for, 1,107,653 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,945,210 | 0 | 0 | 0 | For |
| BlackRock | 2,517,747 | 0 | 0 | 0 | For |
| Fidelity | 1,167,444 | 0 | 0 | 89,946 | Mixed |
| JPMorgan | 586,012 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 237,603 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 212,114 | Withhold |
| Lincoln Financial | 106,009 | 0 | 0 | 56,920 | Mixed |
| Charles Schwab | 161,808 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 158,226 | Withhold |
| EA Series Trust | 0 | 0 | 0 | 128,730 | Withhold |
| TIAA | 119,113 | 0 | 0 | 0 | For |
| Equitable | 103,465 | 0 | 0 | 5,860 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 108,595 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 50,241 | Withhold |
| Nationwide | 0 | 0 | 0 | 31,010 | Withhold |
| Northern Trust | 27,751 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 25,821 | Withhold |
| Bridge Builder Trust | 25,732 | 0 | 0 | 0 | For |
| Pacific Life | 22,273 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 0 | 18,957 | Withhold |
| State Street | 0 | 0 | 0 | 16,311 | Withhold |
| ProShares | 0 | 0 | 0 | 15,591 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 10,636 | Withhold |
| DWS | 0 | 0 | 0 | 9,195 | Withhold |
| American Century | 0 | 0 | 0 | 8,970 | Withhold |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Class I directors: Robert Michael Poole
OVID THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert Michael Poole”): 40,158,684 for, 2,109,527 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 : The Company's stockholders elected all of the nominees for director to serve a three-year term until the Company's 2027 annual meeting of stockholders, or until their respective successors are duly elected and qualified, by the votes set forth in the table below:”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 8,636,568 for, 368,131 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,945,210 | 0 | 0 | 0 | For |
| BlackRock | 2,517,747 | 0 | 0 | 0 | For |
| Fidelity | 1,167,444 | 0 | 0 | 89,946 | Mixed |
| JPMorgan | 586,012 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 237,603 | Withhold |
| BRIDGEWAY FUNDS INC | 212,114 | 0 | 0 | 0 | For |
| Lincoln Financial | 157,509 | 0 | 0 | 5,420 | For |
| Charles Schwab | 161,808 | 0 | 0 | 0 | For |
| Voya | 158,226 | 0 | 0 | 0 | For |
| EA Series Trust | 128,730 | 0 | 0 | 0 | For |
| TIAA | 119,113 | 0 | 0 | 0 | For |
| Equitable | 109,325 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,595 | 0 | 0 | 0 | For |
| Brighthouse | 50,241 | 0 | 0 | 0 | For |
| Nationwide | 31,010 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 27,751 | Withhold |
| John Hancock | 25,821 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,732 | 0 | 0 | 0 | For |
| Pacific Life | 22,273 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,957 | 0 | 0 | 0 | For |
| State Street | 16,311 | 0 | 0 | 0 | For |
| ProShares | 15,591 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 10,636 | 0 | 0 | 0 | For |
| DWS | 9,195 | 0 | 0 | 0 | For |
| American Century | 8,970 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: ADVISORY APPROVAL OF THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.
OVID THERAPEUTICS INC.’s own tally for this item (“2. The compensation paid to the Company's named executive officers, as disclosed in the Proxy Statement”): 40,499,565 for, 1,760,461 against — passed, per its Form 8-K filed June 7, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 : The Company's stockholders approved, on an advisory basis, the compensation paid to the Company's named executive officers, as disclosed in the Proxy Statement, by the votes set forth in the table below:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,945,210 | 0 | 0 | 0 | For |
| BlackRock | 2,517,747 | 0 | 0 | 0 | For |
| Fidelity | 1,257,390 | 0 | 0 | 0 | For |
| JPMorgan | 586,012 | 0 | 0 | 0 | For |
| Dimensional | 237,603 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 212,114 | 0 | 0 | Against |
| Lincoln Financial | 162,929 | 0 | 0 | 0 | For |
| Charles Schwab | 161,808 | 0 | 0 | 0 | For |
| Voya | 158,226 | 0 | 0 | 0 | For |
| EA Series Trust | 128,730 | 0 | 0 | 0 | For |
| TIAA | 119,113 | 0 | 0 | 0 | For |
| Equitable | 109,325 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,595 | 0 | 0 | 0 | For |
| Brighthouse | 50,241 | 0 | 0 | 0 | For |
| Nationwide | 18,410 | 12,600 | 0 | 0 | Mixed |
| Northern Trust | 27,751 | 0 | 0 | 0 | For |
| John Hancock | 25,821 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,732 | 0 | 0 | 0 | For |
| Pacific Life | 22,273 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,957 | 0 | 0 | 0 | For |
| State Street | 16,311 | 0 | 0 | 0 | For |
| ProShares | 15,591 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 10,636 | 0 | 0 | 0 | For |
| DWS | 9,195 | 0 | 0 | 0 | For |
| American Century | 0 | 8,970 | 0 | 0 | Against |
Fund voting reports, all 36 managers: 8,765,660 for, 239,039 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 6,117,400 | 0 | 0 | 0 | For |
| Rubric Capital Management LP | 4,098,355 | 0 | 0 | 0 | For |
| BVF INC/IL | 3,853,818 | 0 | 0 | 0 | For |
| Madison Avenue Partners, LP | 3,672,909 | 0 | 0 | 0 | For |
| BlackRock | 1,465,141 | 0 | 0 | 0 | For |
| JPMorgan | 1,349,401 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,251,679 | 0 | 0 | 0 | For |
| State Street | 1,102,117 | 115 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 625,430 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 616,816 | 0 | 0 | 0 | For |
| Northern Trust | 440,684 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 247,229 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 223,514 | 0 | 0 | Against |
| Prosight Management, LP | 206,007 | 0 | 0 | 0 | For |
| Wellington | 199,590 | 0 | 0 | 0 | For |
| Charles Schwab | 161,822 | 0 | 0 | 0 | For |
| Voya | 158,226 | 0 | 0 | 0 | For |
| Nuveen | 119,113 | 0 | 0 | 0 | For |
| Fidelity | 90,462 | 0 | 0 | 0 | For |
| Citadel | 88,969 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 82,319 | 0 | 0 | 0 | For |
| UBS | 81,608 | 0 | 0 | 0 | For |
| Dimensional | 78,839 | 0 | 0 | 0 | For |
| SCS Capital Management LLC | 75,530 | 0 | 0 | 0 | For |
| Gratus Capital, LLC | 75,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 74 managers: 26,727,983 for, 324,555 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: Ratification of the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
OVID THERAPEUTICS INC.’s own tally for this item (“3. The selection of KPMG LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024”): 57,201,432 for, 1,293,006 against — passed, per its Form 8-K filed June 7, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 : The Company's stockholders ratified the selection of KPMG LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024 by the votes set forth in the table below:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 8,875,969 for, 128,730 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,945,210 | 0 | 0 | 0 | For |
| BlackRock | 2,517,747 | 0 | 0 | 0 | For |
| Fidelity | 1,257,390 | 0 | 0 | 0 | For |
| JPMorgan | 586,012 | 0 | 0 | 0 | For |
| Dimensional | 237,603 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 212,114 | 0 | 0 | 0 | For |
| Lincoln Financial | 162,929 | 0 | 0 | 0 | For |
| Charles Schwab | 161,808 | 0 | 0 | 0 | For |
| Voya | 158,226 | 0 | 0 | 0 | For |
| EA Series Trust | 0 | 128,730 | 0 | 0 | Against |
| TIAA | 119,113 | 0 | 0 | 0 | For |
| Equitable | 109,325 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 108,595 | 0 | 0 | 0 | For |
| Brighthouse | 50,241 | 0 | 0 | 0 | For |
| Nationwide | 31,010 | 0 | 0 | 0 | For |
| Northern Trust | 27,751 | 0 | 0 | 0 | For |
| John Hancock | 25,821 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,732 | 0 | 0 | 0 | For |
| Pacific Life | 22,273 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,957 | 0 | 0 | 0 | For |
| State Street | 16,311 | 0 | 0 | 0 | For |
| ProShares | 15,591 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 10,636 | 0 | 0 | 0 | For |
| DWS | 9,195 | 0 | 0 | 0 | For |
| American Century | 8,970 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 70,944,627 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.15% |
| 2 | BlackRock | 3.55% |
| 3 | Fidelity | 1.77% |
| 4 | JPMorgan | 0.83% |
| 5 | Dimensional | 0.33% |
| 6 | BRIDGEWAY FUNDS INC | 0.30% |
| 7 | Lincoln Financial | 0.23% |
| 8 | Charles Schwab | 0.23% |
| 9 | Voya | 0.22% |
| 10 | EA Series Trust | 0.18% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | EcoR1 Capital, LLC | 8.62% |
| 2 | Rubric Capital Management LP | 5.78% |
| 3 | BVF INC/IL | 5.43% |
| 4 | Madison Avenue Partners, LP | 5.18% |
| 5 | BlackRock | 2.07% |
| 6 | JPMorgan | 1.90% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.76% |
| 8 | State Street | 1.55% |
| 9 | Ensign Peak Advisors, Inc | 0.88% |
| 10 | ACADIAN ASSET MANAGEMENT LLC | 0.87% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Takeda Pharmaceutical Company Limited | 12.38% | DEF14A |
| Jeremy M. Levin | 9.79% | 13G |
| Entities affiliated with Biotechnology Value Fund, L.P. | 9.66% | DEF14A |
| Entities affiliated with EcoR1 Capital, LLC | 8.62% | DEF14A |
| Rubric Capital Management LP | 7.49% | DEF14A |
| Madison Avenue International LP | 5.14% | DEF14A |
| Madison Avenue Partners, LP | 4.02% | 13G |
| Vanguard Group | 3.98% | 13F |
| Geode Capital | 1.78% | 13F |
| State Street | 1.63% | 13F |
Percentages above are of 70,944,627 shares outstanding, as reported by OVID THERAPEUTICS INC. on its Form 10-Q dated May 10, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from OVID THERAPEUTICS INC.’s 10-Q dated May 10, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
OVID THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2025-2026.
proxyvotesnow.com, “OVID THERAPEUTICS (OVID) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/ovid-therapeutics-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.